A letter discussing the potential of mitochondrial organelle transplantation to manage acute and chronic diseases of the nervous system and its potential to attenuate aging effects. The letter suggests creating a neurotherapeutics company called MODERN NEURON based on this technology. It includes a review of relevant literature and existing intellectual property, highlighting the success of mitochondrial transplantation in heart and liver trials and its potential application in neurodegenerative diseases.
documents/EFTA00707641.pdf
{}